KATELYN BALES: Open Payments
NPI 1396222568 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,499 in 58 payments from 18 companies in 2025. Trend: 2023 $1,487 · 2024 $1,768 · 2025 $1,499
Food & beverage: $1,499
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $220 |
| Novo Nordisk Inc | 10 | $188 |
| PFIZER INC. | 10 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $166 |
| KYOWA KIRIN, INC. | 1 | $129 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Lilly USA, LLC | 7 | $115 |
| Abbott Laboratories | 4 | $94 |
| Exact Sciences Corporation | 3 | $52 |
| Astellas Pharma US Inc | 2 | $43 |
Products named: Kerendia, AIRSUPRA, DUPIXENT, Rybelsus, FREESTYLE LIBRE 3, MOUNJARO, ELIQUIS, FARXIGA.
Industry payments across TN — which companies pay providers there.
